OnKure Therapeutics, Inc. (OKUR)
NASDAQ: OKUR · Real-Time Price · USD
2.710
+0.050 (1.88%)
Feb 27, 2026, 4:00 PM EST - Market closed
OnKure Therapeutics Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$32.00
Upside
+1,080.81%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $34 | Strong Buy | Reiterates | $34 | +1,154.61% | Aug 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $40 → $34 | Strong Buy | Maintains | $40 → $34 | +1,154.61% | Mar 18, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $35 → $30 | Buy | Maintains | $35 → $30 | +1,007.01% | Mar 11, 2025 |
| Jones Trading | Jones Trading | Strong Buy Initiates $32 | Strong Buy | Initiates | $32 | +1,080.81% | Jan 28, 2025 |
| Leerink Partners | Leerink Partners | Buy Initiates $33 | Buy | Initiates | $33 | +1,117.71% | Dec 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +1,376.01% | Nov 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +1,376.01% | Oct 17, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $35 | Buy | Initiates | $35 | +1,191.51% | Oct 10, 2024 |